Litigation involving US Patent 9051542

9051542

Genzyme Corporation v. Novartis Gene Therapies, Inc.

active

Docket:: 1:21-cv-01736
Court:: District Court for the District of Delaware
Filed:: 2021-12-10

π Genzyme Corporation Δ Novartis Gene Therapies, Inc.

This ongoing litigation involves Genzyme Corporation asserting claims 5 and 6 of US patent 9051542 against Novartis Gene Therapies, Inc., after claims 1 and 2 were disclaimed by the Patent Owner.

Novartis Gene Therapies, Inc. et al. v. Genzyme Corporation

Petition denied

Docket:: IPR2023-00608
Court:: Patent Trial and Appeal Board
Terminated:: 2023-08-30

Patents:9051542

π Novartis Gene Therapies, Inc.π Novartis Pharmaceuticals Corporation Δ Genzyme Corporation

Novartis challenged claims 5 and 6 of US patent 9051542. The Patent Trial and Appeal Board denied the petition, determining that the Petitioner had not demonstrated a reasonable likelihood of prevailing with respect to any challenged claim.

Untitled case

Not Instituted - Procedural

Docket:: IPR2025-01194
Court:: Patent Trial and Appeal Board

Patents:9051542

An IPR petition concerning US patent 9051542 was filed in 2025 but was not instituted on procedural grounds.